1. Home
  2. ACB vs CRBU Comparison

ACB vs CRBU Comparison

Compare ACB & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aurora Cannabis Inc.

ACB

Aurora Cannabis Inc.

HOLD

Current Price

$3.44

Market Cap

250.1M

Sector

Health Care

ML Signal

HOLD

Logo Caribou Biosciences Inc.

CRBU

Caribou Biosciences Inc.

HOLD

Current Price

$1.91

Market Cap

203.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACB
CRBU
Founded
2013
2011
Country
Canada
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
250.1M
203.9M
IPO Year
2016
2021

Fundamental Metrics

Financial Performance
Metric
ACB
CRBU
Price
$3.44
$1.91
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$10.75
AVG Volume (30 Days)
558.5K
1.2M
Earning Date
02-04-2026
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
3.64
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$6.89
N/A
Revenue Next Year
N/A
$10.48
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.28
$0.66
52 Week High
$6.67
$3.53

Technical Indicators

Market Signals
Indicator
ACB
CRBU
Relative Strength Index (RSI) 41.26 54.05
Support Level $3.28 $1.70
Resistance Level $3.91 $2.07
Average True Range (ATR) 0.13 0.12
MACD 0.00 -0.00
Stochastic Oscillator 7.11 60.98

Price Performance

Historical Comparison
ACB
CRBU

About ACB Aurora Cannabis Inc.

Aurora Cannabis Inc headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company operates in Canada, it has expanded internationally through medical cannabis exporting agreements. The company opertes in Canada, Europe, Australia, and Others, with majority revenue from Canada.

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

Share on Social Networks: